High levels of expression of cytokeratin 5 are strongly correlated with poor survival in higher grades of mucoepidermoid carcinoma

Journal of Clinical Pathology

Volumn 61, Issue 7, 2008, Pages 837-840

  Lueck, N E ^a   Robinson, R A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYTOKERATIN 5; TUMOR MARKER;

ADENOSQUAMOUS CARCINOMA; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CLINICAL ARTICLE; CORRELATION ANALYSIS; FISHER EXACT TEST; FOLLOW UP; HUMAN; LOG RANK TEST; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; STATISTICAL SIGNIFICANCE; ADULT; AGED; CANCER STAGING; FEMALE; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PROGNOSIS; SALIVARY GLAND TUMOR; SURVIVAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, MUCOEPIDERMOID; FEMALE; FOLLOW-UP STUDIES; HUMANS; KERATIN-5; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SALIVARY GLAND NEOPLASMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 47049086260     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2008.055988     Document Type: Article

References (17)

1. Luna MA. Salivary mucoepidermoid carcinoma: revisited. Adv Anat Pathol 2006;13:293-307.
2. Goode RK, Auclair PL, Ellis GL Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer 1998:82:1217-24.
3. Auclair PL, Goode RK, Ellis GL. Mucoepidermoid carcinoma of the intraoral salivary glands: evaluation and application of grading criteria in 143 cases. Cancer 1992;69:2021-30.
4. Brandwein MS, Ivanov K, Wallace Dl, et al. Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol 2001;25:835-45.
5. Martins MD, de Araujo VC, Raitz R, et al. Expression of cytoskeleton proteins in developing human minor salivary glands. Eur J Oral Sci 2002;110:316-21.
6. de Rijn M, Perou CM, Tibshirani R, et al. Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol 2002;161:1991-6.
7. Livasy CA, Perou CM, Karaca G, et al. Identification of a basal-like subtype of breast ductal carcinoma in situ. Human Pathol 2007;38:197-204.
8. Livasy CA, Karaca G, Nanda R, et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol 2006;19:264-71.
9. Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 2004;10:5367-74.
10. van Leaders GJ, Aalders TW, Hulsbergen-van de Kaa CA, et al. Expression of basal cell keratins in human prostate cancer metastasis and cell lines. J Pathol 2001;195:563-70.
11. Dantas da Silveira EJ, Barros SS, Batista de Amorim RF, et al. Cytokeratin profile in mucoepidermoid carcinoma is not related to its histologic grading of malignancy. Exp Mol Pathol 2006;81:72-6.
12. Loyola AM, de Sousa SOM, Araujo NS, et al. Study of minor salivary gland mucoepidermoid carcinoma differentiation based on immunohistochemical expression of cytokeratins, vimentin and muscle-specific actin. Oral Oncol 1998;34:112-8.
13. Pires FR, Chen SY, da Cruz Perez DE, et al. Cytokeratin expression in central mucoepidermoid carcinoma and glandular odontogenic cyst. Oral Oncol 2004;40:545-51.
14. Raimondi AR, Vitale-Cross L, Amornphimoltham P, et al. Rapid development of salivary gland carcinomas upon conditional expression of K-ras driven by the cytokeratin 5 promoter. Am J Pathol 2006;168:1654-65.
15. Vitale-Cross L, Amornphimoltham P, Fisher G, et al. Conditional expression of K-ras in an epithelial compartment that includes the stem cells is sufficient to promote squamous cell carcinogenesis. Cancer Res 2004;64:8804-7.
16. Green FL, ed. American Joint Committee on Cancer: Cancer staging manual. 6th edn. Springer: Chicago, 2002.
17. Chu PG, Weiss LM. Expression of cytokeratin 5/6 in epithelial neoplasms: an immunohistochemical study of 509 cases. Mod Pathol 2002;15:6-10.